Sign Up
OverviewAPI
AltPep, a Seattle biotech startup, developed SOBA-AD test for early Alzheimer's detection, achieving 100% accuracy in symptomatic patients. The company secured $76 million funding, FDA breakthrough device designation, and Health Innovation Award, with plans for FDA approval and research on Alzheimer's treatment and Parkinson's solutions.

Ask a question